IPSC vs PH
Century Therapeutics Inc (IPSC) versus Parker-Hannifin Corporation (PH) — a side-by-side from cached financials, not a winner call.
Century Therapeutics Inc (IPSC) is a biotechnology company listed on US.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
Latest reported IPSC revenue for 2024-12-31 was $6.6M. Net income was -$126.6M. Revenue was up 194.8% from 2023-12-31 to 2024-12-31. IPSC currently screens at market cap $47.8M.
Latest reported PH revenue for 2025-06-30 was $19.85B. Net income was $3.53B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
IPSC currently screens at market cap $47.8M. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Not investment advice. Open the IPSC and PH stock pages for the full models.
Not investment advice.